Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells

Dhong Hyo Kho1, Pratima Nangia-Makker, Vitaly Balan

  • 1Departments of Oncology and Pathology, Wayne State University School of Medicine, Karmanos Cancer Institute, 110 E Warren Ave., Detroit, MI 48201, USA.

Cancer Research
|December 19, 2012
PubMed

Insights

Autocrine motility factor (AMF) binding to HER2 triggers resistance to trastuzumab in breast cancer. Targeting the AMF-HER2 interaction may overcome treatment resistance in HER2-positive patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Trastuzumab is a targeted therapy for HER2-overexpressing breast cancer.
  • Resistance to trastuzumab is a significant clinical challenge in HER2-positive breast carcinoma patients.
  • Understanding resistance mechanisms is crucial for improving patient outcomes.

Purpose of the Study:

  • To elucidate the mechanisms by which breast carcinoma cells develop resistance to trastuzumab.
  • To investigate the role of autocrine motility factor (AMF) in trastuzumab resistance.
  • To identify potential novel therapeutic targets for overcoming trastuzumab resistance.

Main Methods:

  • Investigated the interaction between AMF and HER2 in breast carcinoma cells.
  • Analyzed HER2 phosphorylation and ectodomain shedding.
  • Assessed the activation of phosphoinositide-3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways.
  • Examined the relationship between HER2 expression and AMF secretion.

Main Results:

  • AMF binds to HER2, inducing cleavage to the active p95HER2 form.
  • AMF interaction triggers HER2 phosphorylation and metalloprotease-mediated ectodomain shedding.
  • This activation leads to PI3K and MAPK signaling, bypassing trastuzumab's inhibitory effects.
  • An inverse relationship was observed between HER2 expression and AMF secretion in breast carcinoma cells.

Conclusions:

  • AMF-HER2 interaction contributes to trastuzumab resistance in HER2-positive breast cancer.
  • The AMF-HER2 pathway activates key signaling cascades that promote cancer cell growth despite trastuzumab treatment.
  • Targeting the AMF-HER2 interaction presents a potential novel therapeutic strategy for managing trastuzumab-resistant breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cell Motility through Blebbing01:16

Cell Motility through Blebbing

Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...